CTOs on the Move

Kerr Corp

www.kerrdental.com

 
Kerr Corporation, a subsidiary of Sybron Dental Specialties, is a manufacturer of premiere dental consumables sold both domestically and internationally. Since 1891, Kerr has been developing, manufacturing and products that are used in every dental
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details

Similar Companies

MedRepublic

We`ve created a global health marketplace where patients are empowered to make the healthcare choices that work for them.

Avantis Medical Systems Inc.

Avantis Medical Systems Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Sunnyvale, CA. To find more information about Avantis Medical Systems Inc., please visit www.avantismedical.com

Blueprint Medicines

Blueprint Medicines is developing a new generation of highly selective and potent kinase therapies to dramatically improve the lives of patients with genomically defined diseases. Our approach is rooted in a deep understanding of the genetic blueprint of cancer and other diseases driven by the abnormal activation of kinases. Our ability to identify novel drivers of disease, coupled with our proprietary library of novel and diverse chemical compounds, uniquely enables us to craft kinase therapies against new and difficult-to-drug targets. We are boldly advancing a deep pipeline of highly targeted therapies against previously unaddressed drivers of disease. By focusing on genomically defined subsets of patients, we believe we can identify the people most likely to respond to our therapies, resulting in a more efficient clinical development path with a greater likelihood of success and better outcomes for patients. We see a substantial opportunity in kinase drug discovery and development to deliver breakthrough medicines that allow patients to live longer with better quality of life and prevent recurrences of disease. Kinases are involved in many hallmarks of tumor biology and are proven cancer drug targets. Currently approved drugs focus on less than 5 percent of known kinases, and the function of most kinases is unknown. Led by a team of industry innovators with a track record of bringing life-changing drugs to market, we believe Blueprint Medicines has the experience and expertise to deliver on the tremendous untapped potential of kinase therapies to improve patients’ lives. We don’t think in small steps. We think in giant leaps. We are driven by the pursuit of new ideas, new innovations, and new ways of thinking.

Hunt Memorial Hospital District

March 6, 2006 - As the Hunt Memorial Hospital District continues to develop the final plans for the new Cancer Center, Presbyterian Hospital of Greenville is keeping sight of the softer side of patient care.

Continuing Ed Courses

Continuing Ed Courses is a Poway, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.